Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan F Cowman

Showing results (221-230 of 232) with videos related to

Pageof 24
Sort By:
ACS Infectious Diseases|February 28, 2023
7-<i>N</i>-Substituted-3-oxadiazole Quinolones with Potent Antimalarial Activity Target the Cytochrome <i>bc</i><sub>1</sub> ComplexWilliam Nguyen, Madeline G Dans, Iain Currie, et al.
Chemmedchem|August 30, 2024
Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4Trent D Ashton, Petar P S Calic, Madeline G Dans, et al.
Molecular Systems Biology|April 27, 2022
Molecular profiling reveals features of clinical immunity and immunosuppression in asymptomatic P. falciparum malariaStephanie I Studniberg, Lisa J Ioannidis, Retno A S Utami, et al.
Nature Communications|April 15, 2020
Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathwayGregory M LaMonte, Frances Rocamora, Danushka S Marapana, et al.
BMC Medicine|November 22, 2021
Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccineRebecca Webster, Silvana Sekuloski, Anand Odedra, et al.
Cell Host & Microbe|February 29, 2020
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CyclePaola Favuzza, Manuel de Lera Ruiz, Jennifer K Thompson, et al.
Journal of Medicinal Chemistry|August 12, 2024
Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4Trent D Ashton, Petar P S Calic, Madeline G Dans, et al.
Nature Communications|June 18, 2024
Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1Madeline G Dans, Coralie Boulet, Gabrielle M Watson, et al.
European Journal of Medicinal Chemistry|October 10, 2024
Exploration and characterization of the antimalarial activity of cyclopropyl carboxamides that target the mitochondrial protein, cytochrome bJon Kyle Awalt, Wenyin Su, William Nguyen, et al.
Ebiomedicine|December 7, 2025
MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Josephine Palandri, Manuel de Lera Ruiz, et al.
Pageof 24

Showing results (221-230 of 232) with videos related to

Sort By:
Pageof 24
ACS Infectious Diseases|February 28, 2023
7-<i>N</i>-Substituted-3-oxadiazole Quinolones with Potent Antimalarial Activity Target the Cytochrome <i>bc</i><sub>1</sub> ComplexWilliam Nguyen, Madeline G Dans, Iain Currie, et al.
Chemmedchem|August 30, 2024
Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4Trent D Ashton, Petar P S Calic, Madeline G Dans, et al.
Molecular Systems Biology|April 27, 2022
Molecular profiling reveals features of clinical immunity and immunosuppression in asymptomatic P. falciparum malariaStephanie I Studniberg, Lisa J Ioannidis, Retno A S Utami, et al.
Nature Communications|April 15, 2020
Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathwayGregory M LaMonte, Frances Rocamora, Danushka S Marapana, et al.
BMC Medicine|November 22, 2021
Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccineRebecca Webster, Silvana Sekuloski, Anand Odedra, et al.
Cell Host & Microbe|February 29, 2020
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CyclePaola Favuzza, Manuel de Lera Ruiz, Jennifer K Thompson, et al.
Journal of Medicinal Chemistry|August 12, 2024
Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4Trent D Ashton, Petar P S Calic, Madeline G Dans, et al.
Nature Communications|June 18, 2024
Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1Madeline G Dans, Coralie Boulet, Gabrielle M Watson, et al.
European Journal of Medicinal Chemistry|October 10, 2024
Exploration and characterization of the antimalarial activity of cyclopropyl carboxamides that target the mitochondrial protein, cytochrome bJon Kyle Awalt, Wenyin Su, William Nguyen, et al.
Ebiomedicine|December 7, 2025
MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Josephine Palandri, Manuel de Lera Ruiz, et al.
Pageof 24